A Clinical Study of CAR-T Cells Treatment for Children With CD19+/CD22+ R/R ALL and Lymphoma

Clinical trial NCT04204161 · UNKNOWN

Trial details

NCT number: NCT04204161
Sponsor: Shenzhen BinDeBio Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Relapsed B-cell Acute Lymphoblastic Leukemia, Childhood Refractory B-cell Acute Lymphoblastic Leukemia, Childhood Relapsed/Refractory B-cell Lymphoma, Childhood

Start date: 2019-10-08
Primary completion: 2021-10-30
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.